https://pubmed.ncbi.nlm.nih.gov/38114052

This review discusses the development, synthesis, mechanisms, and clinical use of small-molecule BCR-ABL tyrosine kinase inhibitors, highlighting their role in revolutionizing precision medicine for treating certain leukemias and emphasizing ongoing efforts to improve their efficacy and overcome resistance.